Lorecivivint, a Novel Intraâarticular CLK/DYRK1A Inhibitor and Wnt Pathway Modulator for Treatment of Knee Osteoarthritis: A Phase 2 Randomized Trial
Yazici, Yusuf, McAlindon, Timothy E., Gibofsky, Allan, Lane, Nancy E., Clauw, Daniel, Jones, Morgan, Bergfeld, John, Swearingen, Christopher J., DiFrancesco, Anita, Simsek, Ismail, Tambiah, Jeyanesh,Journal:
Arthritis & Rheumatology
DOI:
10.1002/art.41315
Date:
May, 2020
File:
PDF, 12.62 MB
2020